相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 技术资料
- 克隆性:
单克隆
- 抗体英文名:
Anti-IL-31(Interleuk
- 抗体名:
白细胞介素31抗体
白细胞介素31抗体产品标准
浓缩液(1mg/1ml) 亲和纯化抗体
产品应用
WB=1:100-500 Elisa =1:200-1000 IP=1:20-100 IHC=1:100-500 (石蜡切片需做抗原修复)
白细胞介素31抗体产品说明
IL-31是一种新型T细胞衍生的细胞因子,其功能受体复合物是由IL-31RA/GPL/GLM R和OSMR组成的异二聚体。它们在过敏性和非过敏性疾病中起重要作用。
Interleukin-31 (IL-31) is a recently discovered T-cell cytokine closely related to IL-6 type cytokines and is preferentially produced by T helper type 2 cells. IL-31 activity is mediated through the ligand-induced oligomerization of a dimeric receptor complex containing IL-31 receptor A and oncostatin M receptor. In response to IL-31 binding, these proteins activate the JAK/STAT and the AKT signaling pathways. RNA levels of IL-31 receptor A and oncostatin M receptor are induced in activated monocytes but are expressed constitutively in epithelial cells. IL-31, when overexpressed in transgenic mice, results in the development of pruritis, alopecia and skin lesions, and in humans may result in atopic dermatitis, suggesting that IL-31 may represent a novel target for antipruritic drug development
Interleukin-31 (IL-31) is a recently discovered T-cell cytokine closely related to IL-6 type cytokines and is preferentially produced by T helper type 2 cells. IL-31 activity is mediated through the ligand-induced oligomerization of a dimeric receptor complex containing IL-31 receptor A and oncostatin M receptor. In response to IL-31 binding, these proteins activate the JAK/STAT and the AKT signaling pathways. RNA levels of IL-31 receptor A and oncostatin M receptor are induced in activated monocytes but are expressed constitutively in epithelial cells. IL-31, when overexpressed in transgenic mice, results in the development of pruritis, alopecia and skin lesions, and in humans may result in atopic dermatitis, suggesting that IL-31 may represent a novel target for antipruritic drug development
zk-0225M KLH血蓝蛋白抗体
zk-8546R KRIT1脑海绵状血管畸形蛋白1抗体
zk-9716R KBPKBP蛋白抗体
zk-1094R kappa Opioid receptorkappa型受体抗体
zk-7688R Kininogen-1 heavy chain激肽原1重链抗体
zk-7689R KCNMB1钙激活钾通道蛋白β1抗体
zk-9442R Kv4.2电压门控性钾通道蛋白Kv4.2抗体
zk-9443R phospho-Kv4.2(Thr602)磷酸化电压门控性钾通道蛋白Kv4.2抗体
zk-9444R phospho-Kv4.2(Thr607)磷酸化电压门控性钾通道蛋白Kv4.2抗体
zk-2112R KT3 tagKT3 tag抗体
zk-1963R KLK1激肽释放酶1抗体
zk-1964R KLK3激肽释放酶3/舒血管素3抗体
zk-1965R KLK4激肽释放酶4抗体
zk-9118R KMT1C组蛋白H3赖氨酸9甲基化1C抗体
zk-2494R Kif14 protein驱动蛋白家族Member14蛋白抗体
zk-2130R Ki-67Ki67蛋白抗体
zk-2424R KCNH1钾离子通道蛋白EAG1抗体
zk-1395R KLF6转染抑癌基因KLF6抗体
zk-3649R KLF8KLF样转录因子8抗体
zk-3648R KEAP1胞质接头蛋白Keap1抗体
zk-2303R phospho-KLF5(Ser311)磷酸化肠道内富含的Kruppel样因子5抗体
zk-10495R KMT6 (phospho Ser21)磷酸化抑癌蛋白EZH2抗体
zk-2231R LYRICAEG-1抗体
zk-6309R IL-6白介素6抗体
zk-2200R LDL低密度脂蛋白抗体
zk-12310R LRRC19LRRC19蛋白抗体
zkm-4577M LAMR1(M1S3)层粘连蛋白受体1单克隆抗体
zkm-0940M LAMR1(5D4)层粘连蛋白受体1单克隆抗体
zk-10126R LATT细胞活化连接蛋白抗体
zk-2657R LIX1LIX1抗体
zk-2044R LOX 1凝集素样氧化型低密度脂蛋白受体抗体
zk-2661R MD1MD-1蛋白抗体
zk-2662R MD-2MD-2蛋白抗体
白细胞介素31抗体
zk-8546R KRIT1脑海绵状血管畸形蛋白1抗体
zk-9716R KBPKBP蛋白抗体
zk-1094R kappa Opioid receptorkappa型受体抗体
zk-7688R Kininogen-1 heavy chain激肽原1重链抗体
zk-7689R KCNMB1钙激活钾通道蛋白β1抗体
zk-9442R Kv4.2电压门控性钾通道蛋白Kv4.2抗体
zk-9443R phospho-Kv4.2(Thr602)磷酸化电压门控性钾通道蛋白Kv4.2抗体
zk-9444R phospho-Kv4.2(Thr607)磷酸化电压门控性钾通道蛋白Kv4.2抗体
zk-2112R KT3 tagKT3 tag抗体
zk-1963R KLK1激肽释放酶1抗体
zk-1964R KLK3激肽释放酶3/舒血管素3抗体
zk-1965R KLK4激肽释放酶4抗体
zk-9118R KMT1C组蛋白H3赖氨酸9甲基化1C抗体
zk-2494R Kif14 protein驱动蛋白家族Member14蛋白抗体
zk-2130R Ki-67Ki67蛋白抗体
zk-2424R KCNH1钾离子通道蛋白EAG1抗体
zk-1395R KLF6转染抑癌基因KLF6抗体
zk-3649R KLF8KLF样转录因子8抗体
zk-3648R KEAP1胞质接头蛋白Keap1抗体
zk-2303R phospho-KLF5(Ser311)磷酸化肠道内富含的Kruppel样因子5抗体
zk-10495R KMT6 (phospho Ser21)磷酸化抑癌蛋白EZH2抗体
zk-2231R LYRICAEG-1抗体
zk-6309R IL-6白介素6抗体
zk-2200R LDL低密度脂蛋白抗体
zk-12310R LRRC19LRRC19蛋白抗体
zkm-4577M LAMR1(M1S3)层粘连蛋白受体1单克隆抗体
zkm-0940M LAMR1(5D4)层粘连蛋白受体1单克隆抗体
zk-10126R LATT细胞活化连接蛋白抗体
zk-2657R LIX1LIX1抗体
zk-2044R LOX 1凝集素样氧化型低密度脂蛋白受体抗体
zk-2661R MD1MD-1蛋白抗体
zk-2662R MD-2MD-2蛋白抗体
白细胞介素31抗体
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料
白细胞介素31抗体
询价





